Correlation Between Amylyx Pharmaceuticals and Barclays Capital

Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Barclays Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Barclays Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amylyx Pharmaceuticals and Barclays Capital, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Barclays Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Barclays Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Barclays Capital.

Diversification Opportunities for Amylyx Pharmaceuticals and Barclays Capital

0.57

Correlation Coefficient

Amylyx Pharmaceuticals  Barclays Capital

Very weak diversification

The 3 months correlation between Amylyx and Barclays is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Barclays Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barclays Capital and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Barclays Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barclays Capital has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Barclays Capital go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Barclays Capital

If you would invest  1,937  in Barclays Capital on September 19, 2024 and sell it today you would earn a total of  0.00  from holding Barclays Capital or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	0.26%
Values	Daily Returns

Amylyx Pharmaceuticals  vs.  Barclays Capital

Amylyx Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Barclays Capital

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Barclays Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Barclays Capital is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Amylyx Pharmaceuticals and Barclays Capital

The main advantage of trading using opposite Amylyx Pharmaceuticals and Barclays Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Barclays Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barclays Capital will offset losses from the drop in Barclays Capital's long position.

The idea behind Amylyx Pharmaceuticals and Barclays Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.